NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- The National Kidney Foundation has Updated Two of its Home Dialysis Resources Posted 03-13-2025
- See How Outset Medical is Bringing Home HD into Skilled Nursing Facilities Posted 03-13-2025
- Monogram Health Held a Home Dialysis Summit for its Clinicians Posted 03-13-2025
- Annual Dialysis Conference 2025 is in Las Vegas from 3/13-16/2025 Posted 03-13-2025